Viewing Study NCT00588835


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-03-03 @ 2:29 AM
Study NCT ID: NCT00588835
Status: TERMINATED
Last Update Posted: 2020-11-30
First Post: 2007-12-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
Sponsor: Radboud University Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module